(ARGX) argenx - Performance 66.9% in 12m
Compare ARGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
91.16%
#1 in Group
Rel. Strength
92.72%
#582 in Universe
Total Return 12m
66.93%
#21 in Group
Total Return 5y
342.96%
#5 in Group
P/E 47.0
81th Percentile in Group
P/E Forward 87.0
92th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.24%
79th Percentile in Group
12m Total Return: ARGX (66.9%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
Total Return (including Dividends) | ARGX | XBI | S&P 500 |
---|---|---|---|
1 Month | 12.84% | 5.55% | -0.45% |
3 Months | -2.69% | -9.75% | -6.29% |
12 Months | 66.93% | -5.39% | 13.04% |
5 Years | 342.96% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
1 Month | 83.4% | 70% | 47.5% |
3 Months | -62.2% | -88.1% | -87.3% |
12 Months | 85.8% | -44.4% | 54.3% |
5 Years | 92.2% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #84 | 6.90% | 13.3% |
3 Month | #63 | 7.83% | 3.85% |
12 Month | #20 | 76.4% | 47.7% |
5 Years | #6 | 410% | 109% |
FAQs
Does ARGX argenx outperforms the market?
Yes,
over the last 12 months ARGX made 66.93%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ARGX made -2.69%, while XBI made -9.75%.
Over the last 3 months ARGX made -2.69%, while XBI made -9.75%.
Performance Comparison ARGX vs Indeces and Sectors
ARGX vs. Indices ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.41% | 13.3% | 9.02% | 53.9% |
US NASDAQ 100 | QQQ | 3.49% | 10.9% | 8.31% | 52.0% |
US Dow Jones Industrial 30 | DIA | 4.95% | 15.7% | 9.78% | 57.7% |
German DAX 40 | DAX | 4.77% | 13.1% | -9.07% | 41.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.06% | 16.1% | 12.7% | 62.0% |
Hongkong Hang Seng | HSI | 4.81% | 14.4% | 8.49% | 54.0% |
India NIFTY 50 | INDA | 6.93% | 7.96% | 9.14% | 64.0% |
Brasil Bovespa | EWZ | 6.04% | 10.0% | 3.32% | 73.7% |
ARGX vs. Sectors ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.26% | 13.4% | 3.04% | 43.5% |
Consumer Discretionary | XLY | 4.38% | 13.4% | 7.85% | 52.3% |
Consumer Staples | XLP | 6.47% | 13.7% | 4.92% | 56.0% |
Energy | XLE | 8.67% | 26.9% | 14.2% | 76.3% |
Financial | XLF | 5.52% | 14.9% | 2.09% | 44.3% |
Health Care | XLV | 7.11% | 17.5% | 14.2% | 68.2% |
Industrial | XLI | 4.09% | 12.5% | 7.98% | 56.2% |
Materials | XLB | 6.22% | 16.1% | 16.9% | 71.4% |
Real Estate | XLRE | 4.52% | 13.9% | 8.86% | 48.6% |
Technology | XLK | 2.85% | 10.4% | 12.0% | 56.5% |
Utilities | XLU | 5.69% | 12.7% | 4.60% | 46.1% |
Aerospace & Defense | XAR | 3.38% | 5.86% | -4.86% | 39.5% |
Biotech | XBI | 4.57% | 7.29% | 24.3% | 72.3% |
Homebuilder | XHB | 5.68% | 14.9% | 24.0% | 73.1% |
Retail | XRT | 5.65% | 14.0% | 15.0% | 68.4% |